A front-running team in the race to develop a COVID-19 vaccine has put its trial on hold after a reported “unexplained illness” in one of the trial volunteers. What does that mean for the quick development of a vaccine?

This entry was posted on Thursday, September 10th, 2020 at 7:13 am and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.